Moody Aldrich Partners LLC Arvinas, Inc. Transaction History

Moody Aldrich Partners LLC

  • $473 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022
SELL
$60.27 - $81.57 $5.64 Million - $7.63 Million
-93,587 Closed
0 $0
Q4 2021

Feb 02, 2022
SELL
$65.85 - $96.21 $1.12 Million - $1.63 Million
-16,950 Reduced 15.33%
93,587 $7.69 Million
Q3 2021

Oct 29, 2021
BUY
$73.2 - $107.87 $1.13 Million - $1.66 Million
15,428 Added 16.22%
110,537 $9.08 Million
Q2 2021

Aug 04, 2021
BUY
$60.45 - $84.26 $5.75 Million - $8.01 Million
95,109 New
95,109 $7.32 Million

Others Institutions Holding ARVN

# of Institutions
224
Shares Held
68.7M
Call Options Held
166K
Put Options Held
31.3K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.32B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email